Company · CIK 0000873303 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Sarepta Therapeutics, Inc. · SRPT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2016 SForm 4 → | Oct 19, 4:22 pm EDT | Sandesh MahatmeSenior Vice President, CFO | 30,000 | $50.08 | $1,502,502 | 31,532 | −48.8% | plan? |
| Oct 17, 2016 MForm 4 → | Oct 19, 4:22 pm EDT | Sandesh MahatmeSenior Vice President, CFO | 30,000 | $13.90 | $417,000 | 61,532 | — | plan? |
| Sep 22, 2016 SForm 4 → | Sep 30, 9:58 pm EDT | Shamim RuffSVP, Regulatory Affairs & Qual | 7,311 | $60.00 | $438,660 | 20,239 | −26.5% | plan? late |
| Sep 22, 2016 MForm 4 → | Sep 30, 9:58 pm EDT | Shamim RuffSVP, Regulatory Affairs & Qual | 7,311 | $13.90 | $101,623 | 27,550 | — | plan? late |
| Sep 22, 2016 SForm 4 → | Sep 26, 4:23 pm EDT | Edward M. Kaye M.D.President, CEO & CMO, Director | 40,179 | $60.00 | $2,410,740 | 76,983 | −34.3% | plan? |
| Sep 22, 2016 MForm 4 → | Sep 26, 4:23 pm EDT | Edward M. Kaye M.D.President, CEO & CMO, Director | 40,179 | $8.28 | $332,682 | 117,162 | — | plan? |
| Sep 22, 2016 SForm 4 → | Sep 26, 4:19 pm EDT | David T HowtonSVP, General Counsel | 7,000 | $60.00 | $420,000 | 21,453 | −24.6% | plan? |
| Sep 22, 2016 MForm 4 → | Sep 26, 4:19 pm EDT | David T HowtonSVP, General Counsel | 7,000 | $13.90 | $97,300 | 28,453 | — | plan? |
| Sep 19, 2016 SForm 4 → | Sep 21, 9:31 pm EDT | Jayant AphaleVP, Technical Operations | 35,000 | $50.00 | $1,750,000 | 11,490 | −75.3% | plan? |
| Sep 19, 2016 MForm 4 → | Sep 21, 9:31 pm EDT | Jayant AphaleVP, Technical Operations | 35,000 | $4.62 | $161,700 | 36,490 | — | plan? |
| Sep 19, 2016 SForm 4 → | Sep 21, 9:29 pm EDT | Edward M. Kaye M.D.President, CEO & CMO, Director | 24,352 | $50.00 | $1,217,600 | 76,983 | −24.0% | plan? |
| Sep 19, 2016 MForm 4 → | Sep 21, 9:29 pm EDT | Edward M. Kaye M.D.President, CEO & CMO, Director | 24,352 | $6.94 | $168,941 | 87,388 | — | plan? |
| Sep 19, 2016 SForm 4 → | Sep 21, 9:28 pm EDT | David T HowtonSVP, General Counsel | 9,304 | $50.00 | $465,200 | 21,453 | −30.3% | plan? |
| Sep 19, 2016 AMForm 4 → | Sep 21, 9:28 pm EDT | David T HowtonSVP, General Counsel | 27,589 | $13.90 | $111,200 | 22,757 | — | plan? |
| Sep 19, 2016 AForm 4 → | Sep 21, 9:22 pm EDT | Sandesh MahatmeSenior Vice President, CFO | 24,430 | — | — | 31,532 | — | plan? |
| Sep 14, 2016 SForm 4 → | Sep 16, 4:04 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 24,557 | $30.00 | $736,710 | 76,983 | −24.2% | plan? |
| Aug 31, 2016 FForm 4 → | Sep 2, 4:43 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 1,487 | $26.07 | $38,766 | 101,540 | — | plan? |
| Aug 31, 2016 FForm 4 → | Sep 2, 4:37 pm EDT | Sandesh MahatmeSenior Vice President, CFO | 1,013 | $26.07 | $26,409 | 7,102 | — | plan? |
| Aug 31, 2016 FForm 4 → | Sep 2, 4:34 pm EDT | Jayant AphaleSVP, Technical Operations | 765 | $26.07 | $19,944 | 11,490 | — | plan? |
| Aug 31, 2016 FForm 4 → | Sep 2, 4:32 pm EDT | David T HowtonSVP, General Counsel | 898 | $26.07 | $23,411 | 3,168 | — | plan? |
| Jul 20, 2016 FForm 4 → | Jul 22, 5:20 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 3,001 | $22.46 | $67,402 | 103,027 | — | plan? |
| Apr 20, 2016 FForm 4 → | Apr 22, 4:36 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 3,001 | $19.71 | $59,150 | 106,028 | — | plan? |
| Mar 14, 2016 PForm 4 → | Mar 16, 8:15 pm EDT | M Kathleen BehrensDirector | 75,000 | $16.28 | $1,220,709 | 21,855 | — | plan? |
| Mar 14, 2016 PForm 4 → | Mar 16, 8:09 pm EDT | Richard BarryDirector | 75,000 | $15.66 | $1,174,185 | 3,241,014 | +2.37% | plan? |
| Mar 14, 2016 PForm 4 → | Mar 16, 8:07 pm EDT | Ben Gil PriceDirector | 4,500 | $16.70 | $75,144 | 42,830 | +11.7% | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 9:27 pm EST | Sandesh MahatmeSenior Vice President, CFO | 3,115 | — | — | 8,115 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 9:24 pm EST | Jayant AphaleSVP, Technical Operations | 2,352 | — | — | 12,255 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 9:05 pm EST | Ben Gil PriceDirector | 1,000 | — | — | 38,330 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 9:02 pm EST | M Kathleen BehrensDirector | 1,000 | — | — | 47,166 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:57 pm EST | William Alden GoolsbeeDirector | 1,000 | — | — | 8,166 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:55 pm EST | Jean-Paul KressDirector | 1,000 | — | — | 1,000 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:52 pm EST | Hans Lennart Rudolf WigzellDirector | 1,000 | — | — | 4,666 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:50 pm EST | Claude NicaiseDirector | 1,000 | — | — | 1,000 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:48 pm EST | Richard BarryDirector | 1,000 | — | — | 3,166,014 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:43 pm EST | Edward M. Kaye M.D.SVP Interim CEO & CMO | 4,704 | — | — | 109,029 | — | plan? |
| Feb 29, 2016 AForm 4 → | Mar 2, 8:33 pm EST | David T HowtonSVP, General Counsel | 2,762 | — | — | 4,066 | — | plan? |
| Jan 20, 2016 FForm 4 → | Jan 25, 1:28 pm EST | Edward M. Kaye M.D.SVP Interim CEO & CMO | 3,368 | $13.26 | $44,660 | 103,525 | — | plan? late |
| Oct 20, 2015 FForm 4 → | Oct 22, 6:24 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 3,001 | $26.74 | $80,247 | 106,893 | — | plan? |
| Jul 20, 2015 FForm 4 → | Jul 31, 4:36 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 3,000 | $33.48 | $100,440 | 109,094 | — | plan? late |
| Apr 20, 2015 AForm 4 → | Apr 22, 4:39 pm EDT | Edward M. Kaye M.D.SVP Interim CEO & CMO | 110,783 | — | — | 112,094 | — | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:48 pm EST | Hans Lennart Rudolf WigzellDirector | 1,000 | — | — | 4,666 | — | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:48 pm EST | Ben Gil PriceDirector | 1,000 | — | — | 37,330 | — | plan? |
| Feb 27, 2015 PForm 4 → | Mar 3, 6:48 pm EST | Edward M. Kaye M.D.SVP & Chief Medical Officer | 800 | $11.82 | $9,452 | 1,311 | +157% | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | John HodgmanDirector | 1,000 | — | — | 6,333 | — | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | William Alden GoolsbeeDirector | 1,000 | — | — | 7,166 | — | plan? |
| Feb 27, 2015 PForm 4 → | Mar 3, 6:47 pm EST | Nishan Garabedian ChristopherPresident and CEO, Director | 800 | $11.82 | $9,452 | 29,552 | +2.78% | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | Anthony R ChaseDirector | 1,000 | — | — | 67,194 | — | plan? |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | M Kathleen BehrensDirector | 1,000 | — | — | 46,166 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | William Alden GoolsbeeDirector | 15,000 | — | — | 15,000 | — | |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | Nishan Garabedian ChristopherPresident and CEO, Director | 373,000 | — | — | 365,804 | — | |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | Anthony R ChaseDirector | 15,000 | — | — | 15,000 | — | |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:47 pm EST | M Kathleen BehrensDirector | 15,000 | — | — | 15,000 | — | |
| Feb 27, 2015 AForm 4 → | Mar 3, 6:46 pm EST | Jayant AphaleSVP Technical Operations | 83,000 | — | — | 75,392 | — |